Showing 76–100 of 200 documents
Sorted by hybrid relevance (keyword + semantic via RRF)
Jinhong He, Xiangxi He, Xiaoxin Xie, Yanhua Fu, Xingxing Luo, et al.
… conducted in Guiyang Public Health Treatment Center. Of 46 TB/HIV co-infected patients received DTG + 3TC or DTG/3TC, a total of 42 patients were finally enrolled in the study. The outcomes of interest were successful TB treatment, viral load (VL) suppression, and …
R. S. Alzhanov, Anna V. Pyatibratova, Д. В. Краснов, D. V. Kapustin, S. V. Anufriev
…specific parameters of the COVID-19 course in patients with TB/HIV co-infection, to analyze changes in the lungs caused by COVID-19 in patients with pulmonary tuberculosis and concurrent HIV infection. Subjects and Methods. 68 HIV-infected patients aged 18-66 years old were inclu…
Seid A, Girma Y, Abebe A, Dereb E, Kassa M, et al.
…llenges global TB control and prevention efforts, where the TB/HIV co-infection epidemic makes the situation much worse. The aim of the study was to determine the determinant factors associated with patterns of MDR-TB among pulmonary TB patients in the Northwest Amhara, Ethiopia.…
Hoa NB, Nhung NV
…rbidity and mortality globally. We conducted an analysis of TB/HIV surveillance data to describe the trends in HIV testing coverage and HIV positivity rate among TB patients in Viet Nam, 2011-2017. Main text This was a descriptive study based on review and analysis of surveillanc…
Batoul Okhovat-Isfahani, Saeid Bitaraf, Mohammad Alì Mansournia, Amin Doosti‐Irani
…he global incidence and prevalence of tuberculosis (TB) and TB/HIV according to the human development index
Hayibor KM, Bandoh DA, Asante-Poku A, Kenu E
…ical characteristics were extracted on TB-only-infected and TB/HIV-coinfected patients. The chi-squared test and binary and multiple logistic regression models were used to assess factors associated with adverse treatment outcome. Results Out of the 758 patient records analyzed, …
Kaila Aguiar Soares, Joanna Ehrlich, M. L. de la Cámara, Souleymane Chaloub, Elom Emeka, et al.
<h3>Tweetable abstract</h3> <b>This study provides an update on the implementation of lateral flow LAM testing in national guidelines and identifies the major barriers that may be preventing widespread use of the test</b>https://bit.ly/44NfxZ3
Mukisa Benjamin
Tuberculosis (TB) is a highly infectious disease caused by Mycobacterium tuberculosis, predominantly affecting the lungs and leading to a range of debilitating symptoms. It is a global health concern, with a significant impact on mortality. This study aimed to assess the prevalen…
Pean P, Madec Y, Nerrienet E, Borand L, Laureillard D, et al.
IRIS is a common complication in HIV-infected patients treated for tuberculosis (TB) and cART. Our aim was to evaluate NK cell reconstitution in HIV-infected patients with TB-IRIS compared to those without IRIS. 147 HIV-infected patients with TB from the CAMELIA trial were enroll…
Viviane Ferraz Ferreira de Aguiar, Dayara de Nazaré Rosa de Carvalho, Dandara de Fátima Ribeiro Bendelaque, Rafael Everton Assunção Ribeiro da Costa, Jaqueline Dantas Neres Martins, et al.
Objectives: This study aims to investigate in secondary databases the prevalence of TB / HIV co-infection in the elderly in the metropolitan region of Belém-Pará, Brazil, in the 2001-2018 historical series.
 Methodology: This is an epidemiological, retrospective study with a…
Saskia Janssen, Zul Izhar Mohd Ismail, Thomas Lovelock, Sarah Hugo, Marije Van Schalkwyk, et al.
Contains fulltext : 322446.pdf (Publisher’s version ) (Open Access)
Natalya V. Kuzmina, Н. В. Нелидова
The article describes a clinical case of Kaposi sarcoma in a patient with concurrent tuberculosis, HIV infection with severely compromised T-cell immunity, viral hepatitis B and C, and substances and alcohol abuse. Also, the patient had low adherence to treatment with anti-tuberc…
Mamadou Sow, Alioune Camara, Sidikiba Sidibé, Ibrahima Kaba, Nestor Niouma Leno, et al.
Introduction: The aim was to assess weight gain during tuberculosis treatment in patients co-infected with tuberculosis and HIV. Methods: Tuberculosis patients co-infected with HIV and undergoing tuberculosis treatment in the pneumophtisiology and infectious and tropical diseases…
Jinhong He, Xiangxi He, Xiaoxin Xie, Yanhua Fu, Xingxing Luo, et al.
Introduction Co-infection with tuberculosis (TB) is the leading cause of death in individuals infected with human immunodeficiency virus (HIV)-1. Dolutegravir and lamivudine (DTG+3TC) has recently been recommended as the preferred first-line regimen for the treatment of new and t…
Muhie NS
Background: Tuberculosis increases human immunodeficiency virus replication and accelerates human immunodeficiency virus progression in both tuberculosis and human immunodeficiency virus coinfected patients. The objective of this study was to determine the incidence rate, surviva…
Resende NH, Resende NH, Martins UCM, Ramalho-de-Oliveira D, Silva DID, et al.
Tuberculosis (TB) and human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) pharmacotherapy and the stigma related to both diseases are complex. The patients' subjective experiences with diseases and medications are of utmost importance in pharmaceutical care…
Lungu P, Mushota K, Njelesani E, Sukwa T, Lakhi S, et al.
Background Mycobacterium tuberculosis (TB) remains a disease of global health concern and a leading cause of mortality arising from an infectious agent. Protective immunity to TB remains unclear. Suppressor of cytokine signaling-3 (SOCS3) and signal transduction and activator of …
Konyana SPP, Teixeira NF, Pirjol L, Thwala B, Nkoyane W, et al.
Introduction Cutaneous immune-mediated adverse drug reactions are more prevalent in people with human immunodeficiency virus (PWH). Severe cutaneous adverse drug reactions (SCAR) are a life-threatening subset of cutaneous adverse drug reactions (CADRs) and a significant public he…
Endeshaw Habtamu Wolelaw, Endalk Getasew Hiruy, Asiya Mohammed Abdu, Kebadnew Mulatu Mihretie
**BACKGROUND:** In patients who have tuberculosis and the human immunodeficiency virus, Tuberculosis is the most prevalent opportunistic illness and the main cause of death. However, little is currently, the time to death and its predictors are known, particularly among individua…
B. P. Pirmakhmadzoda, Z. Kh. Tilloeva, Kh. S. Sharifzoda, Olim Kabirov, K. A. Imomnazarova, et al.
The objective of the study: to determine the burden of tuberculosis with concurrent HIV infection in Dushanbe and the prevalence of multiple drug resistant tuberculosis, to assess the treatment efficacy of drug susceptible and drug resistant tuberculosis depending on the HIV stat…
Eang, Mao Tan, Chheng, Phalkun, Natpratan, Chawalit, Kimerling, Michael E
Gengiah S, Connolly C, Yende-Zuma N, Barker PM, Nunn AJ, et al.
Background A quality improvement (QI) collaborative approach to enhancing integrated HIV-Tuberculosis (TB) services may be effective in scaling up and improving the quality of service delivery. Little is known of the role of organizational contextual factors (OCFs) in influencing…
Theresa Musa Hassab, Audrey Hamachila, Aubrey Chichonyi Kalungia, Norman Nyazema, Moses Mukosha, et al.
Tuberculosis (TB) and HIV co-infection pose significant challenges in resource-limited settings, contributing to multi-drug-resistant TB when treatment fails. This study aimed to identify determinants of TB treatment outcomes among HIV/TB co-infected patients in Lusaka, Zambia.A …
Bionghi N, Daftary A, Maharaj B, Msibi Z, Amico KR, et al.
…e-containing TB regimens. Methods Eligible patients were DR-TB/HIV co-infected adults hospitalized for the initiation of Bedaquiline-containing treatment regimens in KwaZulu-Natal, South Africa. A one-way crossover design was used to evaluate levels of adherence and patient accep…
Tesfaye B, Alebel A, Gebrie A, Zegeye A, Tesema C, et al.
Background Tuberculosis and HIV/AIDS are the major public health problems in many parts of the world particularly in resource limited countries like Ethiopia. Although studies have been conducted on the prevalence and associated factors of TB / HIV co-infection in Ethiopia, there…